Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results.

More From Author

Lawyers Should Not Exploit Unfair Advantages

NYT Connections hints and answers for Monday, April 28 (game #687)

Leave a Reply

Your email address will not be published. Required fields are marked *